Vault-13

Eversept Partners, LP

NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08

SEC-registered investment adviser since 2017 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 4
San Francisco, CAUnited States United States1

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$946.9m reported value -11.1% vs Q1 2023
66positions
57.6%in top 10
17 new 20 added 25 reduced 6 sold out vs Q1 2023

Options: 0 call positions (— notional), 5 put positions ($249.2m notional) – listed below, not included above.

Holdings, Q2 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 2,413,787 $117.5m12.40% 12.40% ReducedShares held: Q3 2022 1.4m, Q4 2022 2.7m, Q1 2023 2.8m, Q2 2023 2.4m -406.0k -405,983 -14.4%
2 GSK PLC SPONSORED ADR GSK GSK 2,881,012 $103.8m10.96% 10.96% ReducedShares held: Q3 2022 2.9m, Q4 2022 3.5m, Q1 2023 3.7m, Q2 2023 2.9m -850.5k -850,487 -22.8%
3 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 7,668,044 $57.7m6.10% 6.10% AddedShares held: Q3 2022 4.1m, Q4 2022 4.7m, Q1 2023 6.2m, Q2 2023 7.7m +1.5m +1,473,472 23.8%
4 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 260,398 $57.5m6.07% 6.07% AddedShares held: Q3 2022 255.2k, Q4 2022 232.8k, Q1 2023 222.1k, Q2 2023 260.4k +38.3k +38,291 17.2%
5 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 475,310 $48.9m5.16% 5.16% ReducedShares held: Q3 2022 1.3m, Q4 2022 1.1m, Q1 2023 819.1k, Q2 2023 475.3k -343.8k -343,814 -42.0%
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 2,189,732 $45.8m4.84% 4.84% ReducedShares held: Q3 2022 1.2m, Q4 2022 1.6m, Q1 2023 2.2m, Q2 2023 2.2m -19.3k -19,325 -0.9%
7 COMMUNITY HEALTH SYS INC NEW COM CYH CYH 7,277,856 $32.0m3.38% 3.38% ReducedShares held: Q3 2022 8.8m, Q4 2022 2.0m, Q1 2023 9.1m, Q2 2023 7.3m -1.8m -1,804,449 -19.9%
8 BIO-TECHNE CORP COM TECH TECH 342,637 $28.0m2.95% 2.95% AddedShares held: Q3 2022 0, Q4 2022 16.6k, Q1 2023 188.7k, Q2 2023 342.6k +154.0k +153,978 81.6%
9 VERA THERAPEUTICS INC CL A VERA VERA 1,740,951 $27.9m2.95% 2.95% ReducedShares held: Q3 2022 156.1k, Q4 2022 411.3k, Q1 2023 1.8m, Q2 2023 1.7m -47.6k -47,578 -2.7%
10 INSPIRE MED SYS INC COM INSP INSP 82,445 $26.8m2.83% 2.83% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 82.4k
11 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 785,740 $26.7m2.82% 2.82% AddedShares held: Q3 2022 626.4k, Q4 2022 558.8k, Q1 2023 689.7k, Q2 2023 785.7k +96.1k +96,064 13.9%
12 DANAHER CORPORATION COM DHR DHR 103,345 $24.8m2.62% 2.62% ReducedShares held: Q3 2022 162.5k, Q4 2022 162.6k, Q1 2023 148.7k, Q2 2023 103.3k -45.3k -45,340 -30.5%
13 HCA HEALTHCARE INC COM HCA HCA 80,725 $24.5m2.59% 2.59% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 27.9k, Q2 2023 80.7k +52.8k +52,816 189.2%
14 ILLUMINA INC COM ILMN ILMN 124,052 $23.3m2.46% 2.46% ReducedShares held: Q3 2022 107.0k, Q4 2022 140.1k, Q1 2023 170.5k, Q2 2023 124.1k -46.5k -46,485 -27.3%
15 ICON PLC SHS ICLR ICLR 71,726 $17.9m1.90% 1.90% ReducedShares held: Q3 2022 10.2k, Q4 2022 66.7k, Q1 2023 76.8k, Q2 2023 71.7k -5.1k -5,062 -6.6%
16 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 2,372,113 $16.7m1.76% 1.76% ReducedShares held: Q3 2022 0, Q4 2022 880.5k, Q1 2023 4.5m, Q2 2023 2.4m -2.1m -2,148,611 -47.5%
17 AMNEAL PHARMACEUTICALS INC COM STK CL A AMRX AMRX 5,265,251 $16.3m1.72% 1.72% AddedShares held: Q3 2022 4.7m, Q4 2022 831.0k, Q1 2023 5.2m, Q2 2023 5.3m +82.2k +82,205 1.6%
18 CATALENT INC COM CTLT CTLT 356,875 $15.5m1.63% 1.63% ReducedShares held: Q3 2022 0, Q4 2022 691.7k, Q1 2023 573.6k, Q2 2023 356.9k -216.7k -216,734 -37.8%
19 SERES THERAPEUTICS INC COM COM 3,076,756 $14.7m1.56% 1.56% AddedShares held: Q3 2022 1.9m, Q4 2022 2.2m, Q1 2023 2.5m, Q2 2023 3.1m +540.1k +540,091 21.3%
20 KRYSTAL BIOTECH INC COM KRYS KRYS 106,465 $12.5m1.32% 1.32% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 106.5k
21 AMARIN CORP PLC SPONS ADR NEW SPONS ADR NEW 10,502,109 $12.5m1.32% 1.32% NewShares held: Q3 2022 12.0m, Q4 2022 0, Q1 2023 0, Q2 2023 10.5m
22 ABCAM PLC ADS ADS 499,394 $12.2m1.29% 1.29% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 499.4k
23 CENTENE CORP DEL COM CNC CNC 152,733 $10.3m1.09% 1.09% ReducedShares held: Q3 2022 191.3k, Q4 2022 214.6k, Q1 2023 288.4k, Q2 2023 152.7k -135.7k -135,693 -47.0%
24 IONIS PHARMACEUTICALS INC COM IONS IONS 241,572 $9.9m1.05% 1.05% ReducedShares held: Q3 2022 201.8k, Q4 2022 241.0k, Q1 2023 303.4k, Q2 2023 241.6k -61.8k -61,797 -20.4%
25 VAXCYTE INC COM PCVX PCVX 195,691 $9.8m1.03% 1.03% ReducedShares held: Q3 2022 0, Q4 2022 178.5k, Q1 2023 299.1k, Q2 2023 195.7k -103.4k -103,359 -34.6%
26 TARO PHARMACEUTICAL INDS LTD SHS TARO TARO 250,286 $9.5m1.00% 1.00% AddedShares held: Q3 2022 223.4k, Q4 2022 225.5k, Q1 2023 245.3k, Q2 2023 250.3k +5.0k +5,019 2.0%
27 REPLIGEN CORP COM RGEN RGEN 66,067 $9.3m0.99% 0.99% AddedShares held: Q3 2022 3.6k, Q4 2022 57.0k, Q1 2023 5.7k, Q2 2023 66.1k +60.4k +60,411 1068.1%
28 INFLARX NV COM IFRX IFRX 1,915,113 $8.5m0.90% 0.90% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 1.9m
29 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 692,369 $8.2m0.87% 0.87% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 45.9k, Q2 2023 692.4k +646.5k +646,513 1409.9%
30 MODEL N INC COM MODN MODN 223,168 $7.9m0.83% 0.83% ReducedShares held: Q3 2022 0, Q4 2022 217.9k, Q1 2023 241.9k, Q2 2023 223.2k -18.7k -18,702 -7.7%
31 LIQUIDIA CORPORATION COM NEW LQDA LQDA 925,444 $7.3m0.77% 0.77% AddedShares held: Q3 2022 1.4m, Q4 2022 1.3m, Q1 2023 724.4k, Q2 2023 925.4k +201.0k +201,038 27.8%
32 XENON PHARMACEUTICALS INC COM XENE XENE 171,378 $6.6m0.70% 0.70% ReducedShares held: Q3 2022 259.6k, Q4 2022 275.7k, Q1 2023 203.3k, Q2 2023 171.4k -31.9k -31,894 -15.7%
33 MOLINA HEALTHCARE INC COM MOH MOH 21,254 $6.4m0.68% 0.68% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 21.3k
34 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 1,658,195 $5.9m0.62% 0.62% ReducedShares held: Q3 2022 1.5m, Q4 2022 1.5m, Q1 2023 1.9m, Q2 2023 1.7m -279.9k -279,893 -14.4%
35 SHOCKWAVE MED INC COM SWAV SWAV 20,138 $5.7m0.61% 0.61% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 47.6k, Q2 2023 20.1k -27.4k -27,439 -57.7%
36 HUMANA INC COM HUM HUM 11,927 $5.3m0.56% 0.56% ReducedShares held: Q3 2022 24.6k, Q4 2022 20.9k, Q1 2023 22.8k, Q2 2023 11.9k -10.8k -10,835 -47.6%
37 PENNANT GROUP INC COM PNTG PNTG 431,622 $5.3m0.56% 0.56% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 422.0k, Q2 2023 431.6k +9.6k +9,648 2.3%
38 APELLIS PHARMACEUTICALS INC COM APLS APLS 56,449 $5.1m0.54% 0.54% NewShares held: Q3 2022 0, Q4 2022 154.8k, Q1 2023 0, Q2 2023 56.4k
39 KURA ONCOLOGY INC COM KURA KURA 450,622 $4.8m0.50% 0.50% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 450.6k
40 IQVIA HLDGS INC COM IQV IQV 18,748 $4.2m0.45% 0.45% AddedShares held: Q3 2022 8.3k, Q4 2022 10.9k, Q1 2023 14.4k, Q2 2023 18.7k +4.3k +4,332 30.1%
41 EHEALTH INC COM EHTH EHTH 503,079 $4.0m0.43% 0.43% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.2m, Q2 2023 503.1k -731.2k -731,204 -59.2%
42 MEDPACE HLDGS INC COM MEDP MEDP 15,564 $3.7m0.39% 0.39% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 11.7k, Q2 2023 15.6k +3.9k +3,896 33.4%
43 CUREVAC N V COM CVAC CVAC 357,342 $3.7m0.39% 0.39% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 357.3k
44 SUTRO BIOPHARMA INC COM COM 747,912 $3.5m0.37% 0.37% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 747.9k
45 MERUS N V COM MRUS MRUS 131,226 $3.5m0.36% 0.36% AddedShares held: Q3 2022 276.7k, Q4 2022 184.6k, Q1 2023 129.1k, Q2 2023 131.2k +2.2k +2,170 1.7%
46 AGILENT TECHNOLOGIES INC COM A A 28,460 $3.4m0.36% 0.36% AddedShares held: Q3 2022 21.5k, Q4 2022 11.9k, Q1 2023 13.1k, Q2 2023 28.5k +15.3k +15,350 117.1%
47 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 114,659 $3.2m0.33% 0.33% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 114.7k
48 BIOHAVEN LTD COM BHVN BHVN 131,103 $3.1m0.33% 0.33% ReducedShares held: Q3 2022 0, Q4 2022 185.6k, Q1 2023 185.6k, Q2 2023 131.1k -54.5k -54,492 -29.4%
49 PARATEK PHARMACEUTICALS INC COM PRTK PRTK 1,327,857 $2.9m0.31% 0.31% AddedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 638.5k, Q2 2023 1.3m +689.4k +689,383 108.0%
50 WATERS CORP COM WAT WAT 10,928 $2.9m0.31% 0.31% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 10.9k
51 REVVITY INC COM RVTY RVTY 21,314 $2.5m0.27% 0.27% AddedShares held: Q3 2022 10.9k, Q4 2022 11.2k, Q1 2023 12.3k, Q2 2023 21.3k +9.0k +8,979 72.8%
52 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 427,317 $2.2m0.23% 0.23% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 427.3k
53 GOHEALTH INC CL A NEW CL A NEW 104,820 $2.1m0.22% 0.22% ReducedShares held: Q3 2022 0, Q4 2022 50.5k, Q1 2023 125.1k, Q2 2023 104.8k -20.2k -20,233 -16.2%
54 XOMA ROYALTY CORPORATION COM NEW XOMA XOMA 89,950 $1.7m0.18% 0.18% UnchangedShares held: Q3 2022 88.4k, Q4 2022 86.9k, Q1 2023 90.0k, Q2 2023 90.0k
55 EVOLUS INC COM EOLS EOLS 228,679 $1.7m0.18% 0.18% AddedShares held: Q3 2022 0, Q4 2022 713.8k, Q1 2023 221.6k, Q2 2023 228.7k +7.1k +7,128 3.2%
56 ARGENX SE SPONSORED ADR ARGX ARGX 4,154 $1.6m0.17% 0.17% AddedShares held: Q3 2022 3.5k, Q4 2022 3.5k, Q1 2023 3.8k, Q2 2023 4.2k +318 +318 8.3%
57 ZAI LAB LTD ADR ZLAB ZLAB 55,176 $1.5m0.16% 0.16% ReducedShares held: Q3 2022 0, Q4 2022 0, Q1 2023 172.0k, Q2 2023 55.2k -116.8k -116,823 -67.9%
58 ELEVANCE HEALTH INC COM ELV ELV 2,315 $1.0m0.11% 0.11% NewShares held: Q3 2022 33.0k, Q4 2022 0, Q1 2023 0, Q2 2023 2.3k
59 AFFIMED N V COM COM 1,676,684 $1.0m0.11% 0.11% ReducedShares held: Q3 2022 1.9m, Q4 2022 330.2k, Q1 2023 1.9m, Q2 2023 1.7m -207.1k -207,100 -11.0%
60 GOSSAMER BIO INC COM GOSS GOSS 749,697 $899.6k0.10% 0.10% ReducedShares held: Q3 2022 548.4k, Q4 2022 154.2k, Q1 2023 1.4m, Q2 2023 749.7k -602.4k -602,368 -44.5%
61 AEROVATE THERAPEUTICS INC COM COM 50,242 $861.6k0.09% 0.09% UnchangedShares held: Q3 2022 0, Q4 2022 91.3k, Q1 2023 50.2k, Q2 2023 50.2k
62 UROGEN PHARMA LTD COM URGN URGN 74,797 $774.1k0.08% 0.08% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 74.8k
63 AADI BIOSCIENCE INC COM WHWK WHWK 101,918 $697.1k0.07% 0.07% UnchangedShares held: Q3 2022 101.9k, Q4 2022 101.9k, Q1 2023 101.9k, Q2 2023 101.9k
64 AC IMMUNE SA SHS ACIU ACIU 124,589 $368.2k0.04% 0.04% UnchangedShares held: Q3 2022 124.6k, Q4 2022 124.6k, Q1 2023 124.6k, Q2 2023 124.6k
65 ARS PHARMACEUTICALS INC COM SPRY SPRY 48,788 $326.9k0.03% 0.03% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 48.8k
66 FIBROGEN INC COM COM 5,600 $15.1k0.00% 0.00% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 0, Q2 2023 5.6k

Sold out since Q1 2023

SecurityTickerShares held beforeValue then
BIOGEN INC BIIB BIIB 153,774 $42.8m153.8k shares
AVANTOR INC AVTR AVTR 717,614 $15.2m717.6k shares
INTRA-CELLULAR THERAPIES INC ITCI ITCI 218,726 $11.8m218.7k shares
GUARDANT HEALTH INC GH GH 483,098 $11.3m483.1k shares
TENET HEALTHCARE CORP THC THC 141,892 $8.4m141.9k shares
HESKA CORP HSKA HSKA 26,409 $2.6m26.4k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INVESCO QQQ TR QQQ · Put QQQPut 350,000 $129.3m350.0k shares Reduced
SPDR S&P 500 ETF TR SPY · Put SPYPut 230,000 $102.0m230.0k shares Reduced
AMN HEALTHCARE SVCS INC AMN · Put AMNPut 95,000 $10.4m95.0k shares Added
SPDR SER TR XBI · Put XBIPut 90,000 $7.5m90.0k shares Added
FIBROGEN INC Put Put 38,800 $104.8k38.8k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 CYH 5.7%≈ $26.5m +1.3 pts 13G 2026-02-17